Novadiscovery is a de-risking technology provider specialized in in silico clinical trials supporting biotech and pharma companies, academic research centers and not-for-profit organizations. We help our clients unlock the potential of modeling & simulation to de-risk the R&D of new therapies for the benefit of patients. Based on the Effect Model law, our pioneering approach enables the prediction of the effectiveness of a therapy or the diagnostic value of a biomarker, at the individual and the population level, and compare them with those of competitors. Nova optimizes drug R&D and strengthens healthcare decision-making. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination. We pride ourselves on attracting the most talented individuals in our industry. Our interdisciplinary team combines expertise in biology, medicine, clinical pharmacology, applied mathematics, data science, artificial intelligence and software development.